Enopace Biomedical Receives $5M Investment

Israeli company Enopace Biomedical, an early-stage company focused on the development of a neuromodulation system to treat patients with Heart Failure, has received a $5 million investment from global medical device company Sorin Group. The investing company has said that it will make additional investments upon achievement of development milestones.